Comparison of two commercial platforms and a laboratory developed test for detection of SARS-CoV-2 RNA
Laura Mannonen, Hannimari Kallio-Kokko, Raisa Loginov, Anu Jääskeläinen, Pia Jokela, Jenni Antikainen, Paula Väre, Eliisa Kekäläinen, Satu Kurkela, Hanna Jarva, Maija Lappalainen
doi: https://doi.org/10.1101/2020.07.03.20144758
Laura Mannonen
*HUS Diagnostic Center, HUSLAB, Clinical Microbiology, University of Helsinki and Helsinki University Hospital, Finland
Hannimari Kallio-Kokko
*HUS Diagnostic Center, HUSLAB, Clinical Microbiology, University of Helsinki and Helsinki University Hospital, Finland
Raisa Loginov
*HUS Diagnostic Center, HUSLAB, Clinical Microbiology, University of Helsinki and Helsinki University Hospital, Finland
Anu Jääskeläinen
*HUS Diagnostic Center, HUSLAB, Clinical Microbiology, University of Helsinki and Helsinki University Hospital, Finland
Pia Jokela
*HUS Diagnostic Center, HUSLAB, Clinical Microbiology, University of Helsinki and Helsinki University Hospital, Finland
Jenni Antikainen
*HUS Diagnostic Center, HUSLAB, Clinical Microbiology, University of Helsinki and Helsinki University Hospital, Finland
Paula Väre
*HUS Diagnostic Center, HUSLAB, Clinical Microbiology, University of Helsinki and Helsinki University Hospital, Finland
Eliisa Kekäläinen
*HUS Diagnostic Center, HUSLAB, Clinical Microbiology, University of Helsinki and Helsinki University Hospital, Finland
†Translational Immunology Research Program and Department of Bacteriology and Immunology, University of Helsinki, Helsinki, Finland
Satu Kurkela
*HUS Diagnostic Center, HUSLAB, Clinical Microbiology, University of Helsinki and Helsinki University Hospital, Finland
Hanna Jarva
*HUS Diagnostic Center, HUSLAB, Clinical Microbiology, University of Helsinki and Helsinki University Hospital, Finland
†Translational Immunology Research Program and Department of Bacteriology and Immunology, University of Helsinki, Helsinki, Finland
Maija Lappalainen
*HUS Diagnostic Center, HUSLAB, Clinical Microbiology, University of Helsinki and Helsinki University Hospital, Finland
Article usage
Posted July 06, 2020.
Comparison of two commercial platforms and a laboratory developed test for detection of SARS-CoV-2 RNA
Laura Mannonen, Hannimari Kallio-Kokko, Raisa Loginov, Anu Jääskeläinen, Pia Jokela, Jenni Antikainen, Paula Väre, Eliisa Kekäläinen, Satu Kurkela, Hanna Jarva, Maija Lappalainen
medRxiv 2020.07.03.20144758; doi: https://doi.org/10.1101/2020.07.03.20144758
Comparison of two commercial platforms and a laboratory developed test for detection of SARS-CoV-2 RNA
Laura Mannonen, Hannimari Kallio-Kokko, Raisa Loginov, Anu Jääskeläinen, Pia Jokela, Jenni Antikainen, Paula Väre, Eliisa Kekäläinen, Satu Kurkela, Hanna Jarva, Maija Lappalainen
medRxiv 2020.07.03.20144758; doi: https://doi.org/10.1101/2020.07.03.20144758
Subject Area
Subject Areas
- Addiction Medicine (406)
- Allergy and Immunology (718)
- Anesthesia (211)
- Cardiovascular Medicine (3010)
- Dermatology (256)
- Emergency Medicine (451)
- Epidemiology (12913)
- Forensic Medicine (12)
- Gastroenterology (841)
- Genetic and Genomic Medicine (4711)
- Geriatric Medicine (433)
- Health Economics (742)
- Health Informatics (2992)
- Health Policy (1083)
- Hematology (400)
- HIV/AIDS (946)
- Medical Education (441)
- Medical Ethics (117)
- Nephrology (483)
- Neurology (4498)
- Nursing (239)
- Nutrition (660)
- Oncology (2336)
- Ophthalmology (663)
- Orthopedics (262)
- Otolaryngology (330)
- Pain Medicine (291)
- Palliative Medicine (85)
- Pathology (506)
- Pediatrics (1218)
- Primary Care Research (510)
- Public and Global Health (7084)
- Radiology and Imaging (1571)
- Respiratory Medicine (934)
- Rheumatology (455)
- Sports Medicine (392)
- Surgery (500)
- Toxicology (63)
- Transplantation (215)
- Urology (187)